Social inequalities in early antidepressant discontinuation

Psychiatric Services

Volumn 65, Issue 5, 2014, Pages 618-625

  Bocquier, Aurélie ^a,b   Cortaredona, Sébastien ^a,b   Verdoux, Hélène ^c   Casanova, Ludovic ^a,d   Sciortino, Vincent ^e   Nauleau, Stève ^f   Verger, Pierre ^a,b  

^a OBSERVATOIRE RÉGIONAL DE LA SANTÉ PROVENCE ALPES CÔTE D AZUR   (France)

^b AIX MARSEILLE UNIV   (France)

^c UNIVERSITÉ DE BORDEAUX   (France)

^d AIX MARSEILLE UNIVERSITY   (France)

^e National Health Insurance Fund for Salaried Workers   (France)

^f Department of Studies and Observation Regional Health Agency   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; HYPNOTIC AGENT; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; ARTICLE; COHORT ANALYSIS; CONSULTATION; DRUG COST; FEMALE; FUNDING; GENERAL PRACTITIONER; HEALTH CARE DISPARITY; HUMAN; LOWEST INCOME GROUP; MALE; MENTAL DISEASE; MORBIDITY; NATIONAL HEALTH INSURANCE; PRESCRIPTION; PSYCHIATRIST; SENSITIVITY ANALYSIS; SEX DIFFERENCE; SOCIOECONOMICS; TREATMENT WITHDRAWAL; ADOLESCENT; DEPRESSIVE DISORDER, MAJOR; ECONOMICS; FRANCE; MEDICATION COMPLIANCE; MIDDLE AGED; POVERTY; SOCIAL EXCLUSION; YOUNG ADULT;

ADOLESCENT; ADULT; ANTIDEPRESSIVE AGENTS; COHORT STUDIES; DEPRESSIVE DISORDER, MAJOR; FEMALE; FRANCE; HEALTHCARE DISPARITIES; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; POVERTY; SEX FACTORS; SOCIAL MARGINALIZATION; YOUNG ADULT;

EID: 84901916682     PISSN: 10752730     EISSN: 15579700     Source Type: Journal    
DOI: 10.1176/appi.ps.201300184     Document Type: Article

References (59)

1. Anderson IM, Ferrier IN, Baldwin RC, et al: Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2000 British Association for Psychopharmacology guidelines. Journal of Psychopharmacology 22:343 - 396, 2008
2. Bauer M, Bschor T, Pfennig A, et al: World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders in Primary Care. World Journal of Biological Psychiatry 8:67-104, 2007 (Pubitemid 46690921)
3. National Collaborating Centre for Mental Health: Depression: The Treatment and Management of Depression in Adults (Partial Update of NICE Clinical Guideline 23). NICE clinical guideline 90. London, National Institute for Health and Clinical Excellence, 2009
4. Clinical Guidelines: Outpatient Management of Isolated Depressive Episodes in Adults [in French]. Paris, Agence Nationale d'Accréditation et d'Evaluation en Santé, 2002
5. Demyttenaere K: Risk factors and predictors of compliance in depression. European Neuropsychopharmacology 13(suppl 3): S69-S75, 2003
6. Hansen DG, Vach W, Rosholm JU, et al: Early discontinuation of antidepressants in general practice: association with patient and prescriber characteristics. Family Practice 21:623-629, 2004 (Pubitemid 39654859)
7. Olfson M, Marcus SC, Tedeschi M, et al: Continuity of antidepressant treatment for adults with depression in the United States. American Journal of Psychiatry 163:101-108, 2006 (Pubitemid 43050110)
8. Tournier M, Cougnard A, Boutouaba-Combe S, et al: Duration of antidepressant drug treatment and its determinants in France [in French]. L'Encéphale 37(suppl 1):S36-S41, 2011
9. Moride Y, Du Fort GG, Monette J, et al: Suboptimal duration of antidepressant treatments in the older ambulatory population of Quebec: association with selected physician characteristics. Journal of the American Geriatrics Society 50:1365- 1371, 2002
10. Trifirò G, Tillati S, Spina E, et al: A nationwide prospective study on prescribing pattern of antidepressant drugs in Italian primary care. European Journal of Clinical Pharmacology 69:227-236, 2013
11. Lorant V, Deliège D, Eaton W, et al: Socioeconomic inequalities in depression: a meta-analysis. American Journal of Epidemiology 157:98-112, 2003 (Pubitemid 36077441)
12. Burton C, Anderson N, Wilde K, et al: Factors associated with duration of new antidepressant treatment: analysis of a large primary care database. British Journal of General Practice 62:e104-e112, 2012
13. Bocquier A, Cortaredona S, Verdoux H, et al: Social inequalities in new antidepressant treatment: a study at the individual and neighborhood levels. Annals of Epidemiology 23:99 -105, 2013
14. Watt G: The inverse care law today. Lancet 360:252-254, 2002
15. Hart JT: The inverse care law. Lancet 1: 405-412, 1971
16. Bull SA, Hu XH, Hunkeler EM, et al: Discontinuation of use and switching of antidepressants: influence of patient-physician communication. JAMA 288:1403 - 1409, 2002
17. Lin EH, Von Korff M, Katon W, et al: The role of the primary care physician in patients' adherence to antidepressant therapy.Medical Care 33:67-74, 1995
18. Weich S, Nazareth I, Morgan L, et al: Treatment of depression in primary care: socio-economic status, clinical need and receipt of treatment. British Journal of Psychiatry 191:164-169, 2007 (Pubitemid 47204538)
19. Lu CY, Roughead E: New users of antidepressant medications: first episode duration and predictors of discontinuation. European Journal of Clinical Pharmacology 68:65-71, 2012
20. Donabedian A: Evaluating the quality of medical care: 1966. Milbank Quarterly 83: 691-729, 2005
21. Kivimäki M, Gunnell D, Lawlor DA, et al: Social inequalities in antidepressant treatment and mortality: a longitudinal register study. Psychological Medicine 37:373-382, 2007
22. Anderson IM: Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability. Journal of Affective Disorders 58:19-36, 2000
23. Furukawa TA, Streiner DL, Young LT: Is antidepressant-benzodiazepine combination therapy clinically more useful? A metaanalytic study. Journal of Affective Disorders 65:173 - 177, 2001
24. MacGillivray S, Arroll B, Hatcher S, et al: Efficacy and tolerability of selective serotonin reuptake inhibitors compared with tricyclic antidepressants in depression treated in primary care: systematic review and meta-analysis. BMJ 326:1014-1017, 2003 (Pubitemid 36566861)
25. Sundell KA, Waern M, Petzold M, et al: Socio-economic determinants of early discontinuation of anti-depressant treatment in young adults. European Journal of Public Health 23:433-440, 2013
26. Bao Y, Fox SA, Escarce JJ: Socioeconomic and racial/ethnic differences in the discussion of cancer screening: "between-" versus "within-" physician differences. Health Services Research 42:950-970, 2007 (Pubitemid 46699468)
27. Videau Y, Saliba-Serre B, Paraponaris A, et al: Why patients of low socioeconomic status with mental health problems have shorter consultations with general practitioners. Journal of Health Services Research and Policy 15:76-81, 2010
28. Boisguérin B, Pichetti S: An overview of CMU-C beneficiaries' access to ambulatory care in 2006 [in French]. Etudes et Résultats 629:1-8, 2008
29. Gardarsdottir H, Egberts TC, Stolker JJ, et al: Duration of antidepressant drug treatment and its influence on risk of relapse/ recurrence: immortal and neglected time bias. American Journal of Epidemiology 170:280 - 285, 2009
30. Melfi CA, Chawla AJ, Croghan TW, et al: The effects of adherence to antidepressant treatment guidelines on relapse and recurrence of depression. Archives of General Psychiatry 55:1128-1132, 1998 (Pubitemid 28558286)
31. Verdoux H, Cougnard A, Thiébaut A, et al: Impact of duration of antidepressant treatment on the risk of occurrence of a new sequence of antidepressant treatment. Pharmacopsychiatry 44:96-101, 2011
32. Saliba B, Ventelou B: Complementary health insurance in France. Who pays? Why? Who will suffer from public disengagement? Health Policy 81:166-182, 2007 (Pubitemid 46454234)
33. Base Drugs and Tariff Information. Paris, National Health Insurance Fund of Employees, 2013. Available at www.codage.ext.cnamts.fr/codif/bdm-it/index- presentation.php
34. Dumesnil H, Cortaredona S, Verdoux H, et al: General practitioners' choices and their determinants when starting treatment for major depression: a cross sectional, randomized case-vignette survey. PLoS One 7:e52429, 2012
35. International Classification of Diseases, 10th rev. Geneva, World Health Organization, 1993
36. Merlo J, Chaix B, Yang M, et al: A brief conceptual tutorial of multilevel analysis in social epidemiology: linking the statistical concept of clustering to the idea of contextual phenomenon. Journal of Epidemiology and Community Health 59:443-449, 2005 (Pubitemid 40791027)
37. Chaix B, Chauvin P: The contribution of multilevel models in contextual analysis in the field of social epidemiology: a review of the literature [in French]. Revue d'Epidemiologie et de Sante Publique 50:489-499, 2002 (Pubitemid 35434737)
38. Larsen K, Merlo J: Appropriate assessment of neighborhood effects on individual health: integrating random and fixed effects in multilevel logistic regression. American Journal of Epidemiology 161:81 - 88, 2005
39. Zhang J, Yu KF: What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA 280:1690-1691, 1998 (Pubitemid 28532993)
40. Hansen DG, Søndergaard J, Vach W, et al: Socio-economic inequalities in first-time use of antidepressants: a population-based study. European Journal of Clinical Pharmacology 60:51-55, 2004 (Pubitemid 38471458)
41. Roer K, Fonager K, Bingley P, et al: The use of antidepressants and introduction of new types in different socio-economic groups: a Danish registry-based crosssectional study. Nordic Journal of Psychiatry 64:268-272, 2010
42. Crump C, Sundquist K, Sundquist J, et al: Neighborhood deprivation and psychiatric medication prescription: a Swedish national multilevel study. Annals of Epidemiology 21:231-237, 2011
43. Le Laidier S: Universal health insurance coverage: contribution of complementary protection [in French]. Médecine Sciences 20:105-108, 2004
44. Moustgaard H, Joutsenniemi K, Martikainen P: Does hospital admission risk for depression vary across social groups? A population-based register study of 231,629 middle-aged Finns. Social Psychiatry and Psychiatric Epidemiology (Epub May 28, 2013)
45. Mitchell AJ, Vaze A, Rao S: Clinical diagnosis of depression in primary care: a meta-analysis. Lancet 374:609-619, 2009
46. Kendrick T, King F, Albertella L, et al: GP treatment decisions for patients with depression: an observational study. British Journal of General Practice 55:280-286, 2005 (Pubitemid 40520904)
47. Verger P, Brabis PA, Kovess V, et al: Determinants of early identification of suicidal ideation in patients treated with antidepressants or anxiolytics in general practice: a multilevel analysis. Journal of Affective Disorders 99:253-257, 2007 (Pubitemid 46290667)
48. Gasquet I, Nègre-Pagès L, Fourrier A, et al: Psychotropic drug use and mental psychiatric disorders in France; results of the general population ESEMeD/ MHEDEA 2000 epidemiological study [in French]. L'Encéphale 31:195 - 206, 2005
49. Hyde J, Calnan M, Prior L, et al: A qualitative study exploring how GPs decide to prescribe antidepressants. British Journal of General Practice 55:755-762, 2005 (Pubitemid 41479439)
50. Bao Y, Alexopoulos GS, Casalino LP, et al: Collaborative depression care management and disparities in depression treatment and outcomes. Archives of General Psychiatry 68:627-636, 2011
51. Kelly-Irving M, Rolland C, Afrite A, et al: Patient-physician interaction in general practice and health inequalities in a multidisciplinary study: design, methods and feasibility in the French INTERMEDE study. BMC Health Services Research 9: 66, 2009
52. Bernheim SM, Ross JS, Krumholz HM, et al: Influence of patients' socioeconomic status on clinical management decisions: a qualitative study. Annals of Family Medicine 6:53-59, 2008
53. Chew-Graham CA, Mullin S, May CR, et al: Managing depression in primary care: another example of the inverse care law? Family Practice 19:632-637, 2002 (Pubitemid 35460647)
54. Bauer M, Monz BU, Montejo AL, et al: Prescribing patterns of antidepressants in Europe: results from the Factors Influencing Depression Endpoints Research (FINDER) study. European Psychiatry 23: 66-73, 2008
55. Fairman KA, Drevets WC, Kreisman JJ, et al: Course of antidepressant treatment drug type, and prescriber's specialty. Psychiatric Services 49:1180-1186, 1998 (Pubitemid 28414682)
56. Cases C, Lucas-Gabrielli V, Perronnin M, et al: Explaining the strong disparities observed in the CMUC clientele of independent practitioners? Questions d'économie de la santé 130:1-6, 2008
57. Ockene IS, Tellez TL, Rosal MC, et al: Outcomes of a Latino community-based intervention for the prevention of diabetes: the Lawrence Latino Diabetes Prevention Project. American Journal of Public Health 102:336-342, 2012
58. Welch G, Allen NA, Zagarins SE, et al: Comprehensive diabetes management program for poorly controlled Hispanic type 2 patients at a community health center. Diabetes Educator 37:680 - 688, 2011
59. Kashner TM, Trivedi MH, Wicker A, et al: The impact of nonclinical factors on care use for patients with depression: a STAR*D report. CNS Neuroscience and Therapeutics 15:320-332, 2009